3-Fluoro-N-hydrazinocarbonylmethyl-benzamide, 95.0%, 500mg

(3S,4S)-Pyrrolidine-3,4-diol hydrochloride, 95.0%, 1g

1-(2-METHYL-2H-INDAZOL-6-YL)ETHANONE, 95.0%, 500mg

n-Nonane, 99%, for synthesis, 100 ml, glass packaging

[1,1′-Binaphthalene]-3,3′-dicarbonitrile,2,2′-dihydroxy-, (1S)-, 1g

7-Nitro-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 10g

Methyl 4-chloro-3-methoxy-5-nitrobenzenecarboxylate, 95.0%, 25g

2,5,8,11,14-PENTAOXAOCTADECANE, 95%, 1g

2-Amino-4-methoxypyridine>98.0%(GC)(T)1g

(6S)-6-[4-(morpholin-4-yl)phenyl]-6-(thiophen-3-yl)piperidine-2,4-dione, 97%, 50mg

4-(6-Methyl-2-benzimidazolyl)thiobenzamide, 1g

Pipette tips Mμlti® MiniFlex 0.1-10 μl, round, Box, Non-sterile, 200 Pieces

2-Bromo-1-(3-chlorophenyl)propan-1-one, 95.0%, 500g